Tissue-specific expression of an anti-proliferative hybrid transgene from the human smooth muscle alpha-actin promoter suppresses smooth muscle cell proliferation and neointima formation.
about
Nanoparticulate carriers for the treatment of coronary restenosisTargeting the cell cycle machinery for the treatment of cardiovascular disease.Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes.Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular disease.Adenoviral vector-based strategies for cancer therapy.Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy.
P2860
Q28220309-E7B55E71-4FB4-4FD8-8CD2-8EE788B30B77Q35164884-BFDCFA98-6E23-4064-97B5-B51A68268628Q35648549-9F9E6333-5CA0-4E0A-8951-CF264393C13BQ35814460-C278424D-E39E-4D53-B27E-FCC2085A2259Q37409025-58E18BB7-C014-448B-8E88-011DD244AFF1Q37511128-C2F1F9E9-720A-4ADE-8A25-DA8CE3BA2AFBQ40770884-9B086F6D-0B4E-4A70-B288-D45CFA6A80BF
P2860
Tissue-specific expression of an anti-proliferative hybrid transgene from the human smooth muscle alpha-actin promoter suppresses smooth muscle cell proliferation and neointima formation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Tissue-specific expression of ...... ation and neointima formation.
@en
Tissue-specific expression of ...... ation and neointima formation.
@nl
type
label
Tissue-specific expression of ...... ation and neointima formation.
@en
Tissue-specific expression of ...... ation and neointima formation.
@nl
prefLabel
Tissue-specific expression of ...... ation and neointima formation.
@en
Tissue-specific expression of ...... ation and neointima formation.
@nl
P2093
P2860
P356
P1433
P1476
Tissue-specific expression of ...... ation and neointima formation.
@en
P2093
Antelman D
Avanzini JB
Gregory RJ
P2860
P2888
P304
P356
10.1038/SJ.GT.3301603
P577
2001-12-01T00:00:00Z